UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital City Road Campus, London, UK.
Br J Ophthalmol. 2022 Nov;106(11):1479-1487. doi: 10.1136/bjophthalmol-2021-319994. Epub 2021 Nov 25.
Functional assessments are a fundamental part of the clinical evaluation of patients with inherited retinal diseases (IRDs). Their importance and impact have become increasingly notable, given the significant breadth and number of clinical trials and studies investigating multiple avenues of intervention across a wide range of IRDs, including gene, pharmacological and cellular therapies. Moreover, the fact that many clinical trials are reporting in vision, rather than the previously anticipated structural stability/slowing of degeneration, makes functional evaluation of primary relevance. In this review, we will describe a range of methods employed to characterise retinal function and functional vision, beginning with tests variably included in the clinic, such as visual acuity, electrophysiological assessment and colour discrimination, and then discussing assessments often reserved for clinical trials/research studies such as photoaversion testing, full-field static perimetry and microperimetry, and vision-guided mobility testing; addressing perimetry in greatest detail, given it is commonly a primary outcome metric. We will focus on how these tests can help diagnose and monitor particular genotypes, also noting their limitations/challenges and exploring analytical methodologies for better exploiting functional measurements, as well as how they facilitate patient inclusion and stratification in clinical trials and serve as outcome measures.
功能评估是遗传性视网膜疾病(IRDs)患者临床评估的一个基本组成部分。鉴于针对多种 IRD 进行了大量临床试验和研究,包括基因、药理学和细胞疗法,这些试验和研究探索了多种干预途径,因此功能评估的重要性和影响变得越来越显著。此外,许多临床试验报告的是视力改善,而不是以前预期的结构稳定性/退行速度减缓,这使得功能评估变得尤为重要。在这篇综述中,我们将描述一系列用于描述视网膜功能和功能性视力的方法,首先是临床上各种不同的测试,例如视力、电生理评估和颜色辨别,然后讨论通常保留给临床试验/研究的评估,如光回避测试、全视野静态视野检查和微视野检查以及视力引导的移动性测试;我们将详细讨论视野检查,因为它通常是主要的结果指标。我们将重点介绍这些测试如何帮助诊断和监测特定的基因型,同时注意它们的局限性/挑战,并探讨更好地利用功能测量的分析方法,以及它们如何促进临床试验中的患者纳入和分层,并作为结果衡量标准。